Formulation containing glucose associated with 1,2,3-propanetriol for the prevention and treatment of hypoglycemia

摘要

This invention describes a product consisting of a combination of glucose and 1,2.3 - propanotriol whose goal is the treatment and prevention of hypoglycemia of short and long duration of iatrogenic nature (resulting from treatment with drugs) and non iatrogenic (hipoglicemiThe reactive hypoglycaemia associated with physical exercise, pregnancy, endocrinopatias). This product is different from already available for presenting an effect more potent and lasting.In addition has the advantage of involving the employment of two natural substances of low cost and toxicity produced by our body in response to hypoglycaemia.Glucose is present in the formulations in an amount ranging from 5 to 50 grams, while the 1,2,3-propanetriol quantity of 3.15 to 12.6 grams.The volume of the solution in pharmaceutical forms for oral or parenteral administration can vary from 5 ml to 1000 ml.